LabPulse.com staff writersAlzheimer'sQuest adds new biomarker test to Alzheimer's portfolioQuest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.April 23, 2024LawsuitBio-Techne files EU patent infringement suit against Molecular InstrumentsLife sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.April 23, 2024CollaborationIpsen, Skyhawk to collaborate on drug discovery for rare neurological disordersBiopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.April 22, 2024Point-of-Care TestingScout secures CARB-X grant to advance diagnostic test developmentScout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.April 22, 2024Research and DevelopmentFujifilm Diosynth Biotechnologies confirms layoffsFujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.April 19, 2024Mergers & AcquisitionsBruker to acquire NanoString for $392.6MNanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.April 18, 2024Trends and FinanceDermTech receives delisting warning from NasdaqMelanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.April 17, 2024CollaborationNightingale Health to open U.S. lab, collaborate with Englander Institute at Weill CornellPreventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.April 17, 2024Trends and FinanceCo-Diagnostics opens manufacturing facility in UtahMolecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.April 16, 2024Diagnostic TechnologiesVeracyte to share bundle of genomic classifier studies at AUA 2024Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.April 16, 2024Previous PagePage 4 of 343Next PageTop StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community